Skip to main content
Main navigation
Home
About pCPA
Who We Are
Governance
FAQs
Negotiations
Recent Updates
Forms and Publications
Brand Name Drugs
Negotiations Status
Negotiation Process
Generic Drugs
Biologics/Biosimilars
Contact Us
EN
FR
Akynzeo (netupitant/palonosetron)
pCPA File Number:
21050
Negotiation Status:
Concluded with an LOI
Indication(s):
Nausea and vomiting (chemotherapy induced) prevention
Sponsor/Manufacturer:
Purdue Pharma
CADTH Project Number:
SR0548-000
pCPA Engagement Letter Issued:
2018-09-19
Negotiation Process Concluded:
2019-04-24